Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Rheumatology in Perspective · by Olga Goodman, MD · A RheumaView publication

Rheumatology meets dermatology

The Treatment Works. Why Is My Skin Acting Up?

An uncommon skin reaction during biologic treatment, why it happens, and why it often does not mean parting with a medicine that helps

Open demo · full guide free after registration
Fictional patient in a sunlit kitchen reaching for a jar of pickles with a psoriasis-like elbow patch
Anna’s story is fictional. The illustration is editorial, not a photograph of an actual patient.

Anna has rheumatoid arthritis. For most of last year her hands were swollen every morning, and opening a jar of pickles turned into a negotiation in which the jar held all the cards.

Then her rheumatologist started a biologic, and it worked. The swelling went down, morning stiffness shrank from two hours to a few minutes, and from then on the jar lost every negotiation.

Eight months later Anna’s scalp began to itch and flake. She blamed the shampoo and changed brands twice, with no effect. When a couple of dry, scaly patches appeared on her elbows as well, a dermatologist took a look and said they resembled psoriasis.

Anna was puzzled. She had never had psoriasis, and her injection is also used to treat it. Her first impulse was to stop the injections that same evening. Her second, much better impulse was to call her rheumatologist.

First, the good news

What Anna noticed has a name, and her doctors had seen it before. During treatment with TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab pegol, golimumab and their biosimilars), a small number of people develop patches on the skin that look like psoriasis. Doctors call this paradoxical psoriasis. Many cases are manageable, but lesions on the palms or soles can sometimes be painful or disabling.

It is uncommon. Across studies, approximately 2–5 out of 100 people treated with TNF inhibitors develop psoriasis-like lesions, although estimates vary. The scalp, palms and soles are common sites. Dermatologists have well-established treatments, but some reactions substantially affect daily life. In many cases the medicine that is helping the joints can stay.

TNF inhibitors block tumor necrosis factor (TNF), one of the main signals that keeps inflammation going. That is why they help in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, Crohn’s disease, ulcerative colitis and psoriasis itself. Where they fit in RA treatment is explained in Biologics and JAK Inhibitors. What they do inside a psoriasis plaque is shown in Psoriasis from the inside out.

Not all TNF inhibitors are approved for all the diseases listed here; indications differ by individual drug.

A new rash needs medical assessment. Do not stop or skip a biologic on your own. A rapidly spreading painful rash, blistering, mouth or eye lesions, or fever requires urgent assessment; breathing difficulty or facial swelling may require emergency care.

Continue reading — free after registration

Discover why immune pathways shift, how doctors distinguish rashes, and when a treatment can safely continue.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Biologic therapyDermatologyMedication safetyParadoxical psoriasisPsoriasisRheumatoid arthritisskinTNF inhibitors